ECIA ENCISION INC
Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 930775 · Fiscal year ends 03/31
Financial factors as of 2025-09-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-3.0%
TTM net income YoY45.0%
TTM EPS YoY50.0%
Revenue 3-yr CAGR-5.3%
Net income 3-yr CAGR—
Margins
Gross margin52.6%
Operating margin-5.1%
Net margin-6.0%
FCF margin-8.6%
EBITDA margin-3.7%
Returns
ROE-21.4%
ROA-10.1%
ROIC (approx.)-15.5%
Asset turnover1.66x
Leverage & solvency
Liabilities / assets54.0%
Debt / equity0.00x
Current ratio2.28x
Interest coverage-5.69x
Cash quality & payout
Operating cash flow / net income1.29x
Accruals ratio2.9%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q22025-09-30 | 2026Q12025-06-30 | 2025Q4*2025-03-31 | 2025Q32024-12-31 | 2025Q22024-09-30 | 2025Q12024-06-30 | 2024Q4*2024-03-31 | 2024Q32023-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.53M | $1.60M | $1.58M | $1.59M | $1.76M | $1.63M | $1.52M | $1.58M |
| Cost of revenue | $830,717 | $724,269 | $693,564 | $735,291 | $926,906 | $688,268 | $841,155 | $854,325 |
| Gross profit | $697,333 | $878,459 | $889,852 | $850,290 | $828,482 | $942,663 | $683,389 | $727,239 |
| R&D expense | $201,392 | $165,440 | $159,652 | $138,804 | $155,515 | $139,180 | $201,543 | $151,077 |
| SG&A expense | $358,639 | $328,198 | $320,104 | $355,200 | $373,405 | $351,903 | $414,024 | $351,569 |
| Operating income | -$258,491 | -$19,780 | -$20,537 | -$20,867 | -$158,918 | $28,343 | -$329,532 | -$189,399 |
| Interest expense | $11,384 | $18,009 | $17,248 | $9,508 | $10,598 | $6,369 | $10,225 | $21,065 |
| Pretax income | -$267,833 | -$41,133 | -$47,308 | -$24,668 | -$170,262 | $22,041 | -$336,671 | -$207,130 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$267,833 | -$41,133 | -$47,308 | -$24,668 | -$170,262 | $22,041 | -$336,671 | -$207,130 |
| EBITDA | -$232,698 | $2,997 | $3,001 | -$5,537 | -$135,715 | $47,665 | -$308,671 | -$168,817 |
| EPS (basic) | -0.02 | 0.00 | — | 0.00 | -0.01 | 0.00 | — | -0.02 |
| EPS (diluted) | -0.02 | 0.00 | — | 0.00 | -0.01 | 0.00 | — | -0.02 |
| Weighted avg. shares (diluted) | 14.19M | 11.88M | — | 11.88M | 11.88M | 11.88M | — | 11.77M |
| Balance sheet | ||||||||
| Cash & equivalents | $71,731 | $47,918 | $257,433 | $347,919 | $230,014 | $270,444 | $42,509 | $99,239 |
| Receivables | $761,947 | $749,426 | $786,471 | $779,900 | $817,002 | $816,149 | $891,129 | $923,112 |
| Inventory | $1.47M | $1.53M | $1.48M | $1.36M | $1.16M | $1.32M | $1.40M | $1.55M |
| Current assets | $2.45M | $2.45M | $2.61M | $2.69M | $2.28M | $2.51M | $2.43M | $2.71M |
| PP&E, net | $250,016 | $233,847 | $244,757 | $269,768 | $266,125 | $251,760 | $254,004 | $268,715 |
| Intangibles | $161,427 | $166,708 | $171,890 | $175,233 | $169,283 | $166,473 | $164,010 | $165,567 |
| Total assets | $4.06M | $4.13M | $3.67M | $3.86M | $3.52M | $3.82M | $3.81M | $4.29M |
| Current liabilities | $1.07M | $1.28M | $1.58M | $1.61M | $1.14M | $1.19M | $1.07M | $1.06M |
| Total liabilities | $2.19M | $2.51M | $2.02M | $2.17M | $1.82M | $1.96M | $1.98M | $2.09M |
| Shareholders' equity | $1.86M | $1.62M | $1.65M | $1.69M | $1.70M | $1.86M | $1.83M | $2.19M |
| Shares outstanding | — | 11.88M | 11.88M | 11.88M | 11.88M | 11.88M | 11.86M | 11.77M |
| Cash flow statement | ||||||||
| Operating cash flow | -$126,641 | -$115,508 | -$201,802 | -$45,845 | $75,171 | $117,528 | -$10,963 | $158,355 |
| Capital expenditure | $36,680 | $6,535 | -$6,919 | $18,775 | $28,415 | $14,144 | -$1 | $11,929 |
| Free cash flow | -$163,321 | -$122,043 | -$194,883 | -$64,620 | $46,756 | $103,384 | -$10,962 | $146,426 |
| Investing cash flow | -$48,463 | -$6,685 | $4,818 | -$24,925 | -$40,377 | -$19,541 | -$4,595 | -$15,379 |
| Financing cash flow | $198,917 | -$87,322 | $106,498 | $188,675 | -$75,224 | $129,948 | -$41,172 | -$349,738 |
| Depreciation & amortization | $25,793 | $22,777 | $23,538 | $15,330 | $23,203 | $19,322 | $20,861 | $20,582 |
| Stock-based compensation | $10,532 | $12,119 | $12,475 | $9,964 | $12,637 | $12,374 | $39,379 | $27,158 |
Free plan shows the latest 8 periods; Pro shows all 62 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.